Early prediction of treatment failure in severe community-acquired pneumonia: The PRoFeSs score

• Tipo: Artigo em Revista Científica Internacional
• Data: 2019

Autores

Pereira, JM (Autor) Outra; Laszczynska, O (Autor) Outra; Azevedo A (Autor) FMUP; Basilio, C (Autor) Outra; Sousa Dias, C (Autor) Outra; Mergulhao, P (Autor) FMUP; Paiva, J-A (Autor) FMUP

Revista

Título: Journal of Critical Care

Vol. 53

Páginas: 38-45

ISSN: 0883-9441

Editora: Elsevier

Indexação

ISI Web of Knowledge - 6 Citações

Scopus - 8 Citações

Outras Informações

ID Authenticus: P-00Q-NKP

DOI: 10.1016/j.jcrc.2019.05.020

Abstract (EN): Purpose: To identify a single/panel of biomarkers and to provide a point score that, after 48 h of treatment, could early predict treatment failure at fifth day of Intensive Care Unit (ICU) stay in severe community-acquired pneumonia (SCAP) patients. Materials and methods: Single-center, prospective cohort study of 107 ICU patients with SCAP. Primary outcome included death or absence of improvement in Sequential Organ Failure Assessment score by >= 2 points within 5 days of treatment. Biomarkers were evaluated within 12 h of first antibiotic dose (D1) and 48 h after the first assessment (D3). Results: A model based on Charlson's score and a panel of biomarkers (procalcitonin on D1 and D3, B-natriuretic peptide on D1, D-dimer and lactate on D3) had good discrimination for primary outcome in both derivation (AUC 0.82) and validation (AUC 0.76) samples andwas well calibrated (X-2= 0.98; df= 1; p=. 32). A point score system (PRoFeSs score) built on the estimates of regression coefficients presented good discrimination (AUC 0.81; 95% Confidence Interval 0.72-0.89) for primary outcome. Conclusions: In SCAP, a combination of biomarkersmeasured at admission and 48 h latermay early predict treatment failure. PRoFeSs score may recognize patients with poor short-term prognosis. (C) 2019 Published by Elsevier Inc.

Idioma: Inglês

Tipo (Avaliação Docente): Científica

Nº de páginas: 8